Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 1, 2007, Pages

  Yamashita, Makiko ^a   Tsuji, Shoutaro ^a   Nishiyama, Akihito ^a   Myrvik, Quentin N ^c   Henriksen, Ruth Ann ^b   Shibata, Yoshimi ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Florida Atlantic Univ ^*

Author keywords

Autoimmune disease; Nuclear envelope; Prostaglandin E2

Indexed keywords

BCG VACCINE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CATALYSIS; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISSOCIATION; FEMALE; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN CELL;

ANIMALS; BCG VACCINE; CELL MEMBRANE; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOPLASM; DINOPROSTONE; ENZYME INDUCTION; FEMALE; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MICE; MICE, INBRED C57BL; NUCLEAR ENVELOPE; PHAGOCYTOSIS; PROTEIN TRANSPORT; SPLEEN; TIME FACTORS; VACCINES, INACTIVATED;

MUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 34547122730     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00346.2006     Document Type: Article

References (37)

1. + T cells. J Immunol 175: 1483-1490, 2005.
2. Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70: 849-860, 2001.
3. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257: 539-542, 1992.
4. Chan ED, Morris KR, Belisle JT, Hill P, Remigio LK, Brennan PJ, Riches DW. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κ B signaling pathways. Infect Immun 69: 2001-2010, 2001.
5. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol 176: 3087-3097, 2006.
6. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
7. 2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-γ. J Immunol 136: 1820-1827, 1986.
8. Fels AO, Pawlowski NA, Abraham EL, Cohn ZA. Compartmentalized regulation of macrophage arachidonic acid metabolism. J Exp Med 163: 752-757, 1986.
9. Fitzgerald TJ. The Th1/Th2-like switch in syphilitic infection: is it detrimental? Infect Immun 60: 3475-3479, 1992.
10. Gangadharam PR, Edwards CK 3rd. Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare. Am Rev Respir Dis 130: 834-838, 1984.
11. + hematopoietic progenitors. Blood 107: 870-879, 2006.
12. 2. J Leukoc Biol 61: 712-720, 1997.
13. Humes JL, Burger S, Galavage M, Kuehl FA Jr, Wightman PD, Dahlgren ME, Davies P, Bonney RJ. The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J Immunol 124: 2110-2116, 1980.
14. Johnson WJ, Sung CP. Rat macrophage treatment with lipopolysaccharide leads to a reduction in respiratory burst product secretion and a decrease in NADPH oxidase affinity. Cell Immunol 108: 109-119, 1987.
15. Liou JY, Deng WG, Gilroy DW, Shyue SK, Wu KK. Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem 276: 34975-34982, 2001.
16. Liou JY, Shyue SK, Tsai MJ, Chung CL, Chu KY, Wu KK. Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem 275: 15314-15320, 2000.
17. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995.
18. 2α is important but not obligatory for coupling with cyclooxygenases. FEBS Lett 546: 251-256, 2003.
19. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792, 2000.
20. Otto JC, Smith WL. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J Biol Chem 269: 19868-19875, 1994.
21. 2 production by nitric oxide in activated murine macrophages. J Immunol 162: 4191-4197, 1999.
22. Power CA, Wei G, Bretscher PA. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun 66: 5743-5750, 1998.
23. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylactic vaccination against HIV. Science 260: 1270-1272, 1993.
24. 89Sr-treated mice with bone marrow from Corynebacterium parvum primed donors. Reg Immunol 2: 169-175, 1989.
25. 89Sr. Am J Pathol 127: 75-82, 1987.
26. 2. Blood 83: 3316-3323, 1994.
27. Shibata Y, Foster LA, Kurimoto M, Okamura H, Nakamura RM, Kawajiri K, Justice JP, Van Scott MR, Myrvik QN, Metzger WJ. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ. J Immunol 161: 4283-4288, 1998.
28. + splenic macrophage formation - role of IL-10 and bone marrow precursors. J Leukoc Biol 80: 590-598, 2006.
29. 2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG. J Leukoc Biol 78: 1281-1290, 2005.
30. 2 biosynthesis between spleen and bone marrow macrophages. J Leukoc Biol 77: 544-551, 2005.
31. Shibata Y, Volkman A. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen. J Immunol 135: 3897-3904, 1985.
32. 2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem Pharmacol 61: 1153-1160, 2001.
33. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.
34. Spencer AG, Thuresson E, Otto JC, Song I, Smith T, DeWitt DL, Garavito RM, Smith WL. The membrane binding domains of prostaglandin endoperoxide H synthases 1 and 2. Peptide mapping and mutational analysis. J Biol Chem 274: 32936-32942, 1999.
35. Tripp CS, Unanue ER, Needleman P. Monocyte migration explains the changes in macrophage arachidonate metabolism during the immune response. Proc Natl Acad Sci USA 83: 9655-9659, 1986.
36. 2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775-779, 1995.
37. 2 promotes the survival of bone marrow-derived dendritic cells. J Immunol 173: 6955-6964, 2004.